10-11 Gbs General Neuro 2nd Year

  • Upload
    sridhar

  • View
    217

  • Download
    0

Embed Size (px)

Citation preview

  • 7/29/2019 10-11 Gbs General Neuro 2nd Year

    1/29

    GUILLAIN-BARRE SYNDROME

  • 7/29/2019 10-11 Gbs General Neuro 2nd Year

    2/29

    GBS

    Eponym that encompasses acute immune-

    mediated polyneuropathies

    Peripheral nerve myelin is target of an immuneattack

    Starts at level of nerve root=conduction blocks &

    muscle weakness

    Eventually get widespread patchy demyel=increased paralysis

  • 7/29/2019 10-11 Gbs General Neuro 2nd Year

    3/29

    PATHOPHYSIOLOGY

    Usually postinfectious

    Immune-mediated: infectious agentsthought to induce Ab production against

    specific gangliosides/glycolipidsLymphocytic infiltration of spinal

    roots/peripheral nerves & then macrophage-mediated, multifocal stripping of myelin

    Result: defects in the propagation ofelectrical nerve impulses, with eventualconduction block and flaccid paralysis

  • 7/29/2019 10-11 Gbs General Neuro 2nd Year

    4/29

    CLINICAL FEATURES:

    Progressive, fairly symmetric muscle weakness

    -typically starts in proximal legs

    -10% will 1st develop weakness in face or arms

    -severe resp muscle weakness in 10-30% pts

    -oropharyngeal weakness in ~ 50%

    Absent or depressed DTR

    Often prominent severe pain in lower back

    Common to have paresthesias in hands and feet

    Dysautonomia is very common: tachycardia, urinaryretention, hypertenison alternating w/ hypotension,ileus

  • 7/29/2019 10-11 Gbs General Neuro 2nd Year

    5/29

    DIAGNOSIS:

    Albuminocytologic dissociation: elevated CSFprotein w/ normal WBC (80-90% pts)

    Electromyography (EMG) helps confirm diagnosis =prolonged or absent F waves

  • 7/29/2019 10-11 Gbs General Neuro 2nd Year

    6/29

    NINDS EXPERT CONSENSUS:

    Reqd Features for dx:

    1. Progressive weakness of > than 1 limb

    2. Areflexia

    Supportive Features:~progression of Sx over days to 4 weeks

    ~relative symmetry

    ~CN involv esp b/l facial n weakness

    ~autonomic dysfunction ~EMG features

    ~elev CSF protein w/ cell count ,10 mm3

  • 7/29/2019 10-11 Gbs General Neuro 2nd Year

    7/29

  • 7/29/2019 10-11 Gbs General Neuro 2nd Year

    8/29

    GBS=HETEROGENOUSSYNDROMEW/VARIANTFORMS

    Think of AIDP as the traditional form asdescribed previously, accts for 85-90%

    Miller Fisher Syndrome: opthalmoplegia,

    ataxia, and areflexia (5%). GQ1b antibody. Only1/4th w/ extremity weakness

    AMAN: selective involv of motor nerves, DTRsare preserved, more common in Japan/China,almost all preceded by Campylobacter infxn

    AMSAN: more severe form of AMAN +sensory

  • 7/29/2019 10-11 Gbs General Neuro 2nd Year

    9/29

    DDXOF POLYNEUROPATHY:

    Arsenic poisoning

    N-Hexane (glue sniffing)

    Vasculitis

    Lyme DiseaseTick paralysis

    Sarcoidosis

    Leptomeningeal Dz

    Paraneoplastic Dz

    Critical Illness

  • 7/29/2019 10-11 Gbs General Neuro 2nd Year

    10/29

  • 7/29/2019 10-11 Gbs General Neuro 2nd Year

    11/29

    SUPPORTIVE CARE

    Monitor Resp status closely (follow NIFs), up to30% may req ventilatory support

    In severe cases, intrarterial monitoring may benecessary given the gisngifcant blood pressurefluctuations

    Neuropathic pain plagues most, often managed w/Gabapentin or Carbamazepine

  • 7/29/2019 10-11 Gbs General Neuro 2nd Year

    12/29

    DISEASE MODIFYING TREATMENT

    IVIG : typically given for 5 d at 0.4 gram/kg/d(may need to extend course depending onresponse)

    Plasmapheresis: usually 4-6 treatments

    over 8-10 days

    The choice b/w plasma exchange and IVIG isdep on availability, pt contraindications, etc.

    Because of ease of administration, IVIG isfrequently preferred. The cost and efficacyof the 2 treatments are comparable.Glucocorticoids have NO ROLE!!

  • 7/29/2019 10-11 Gbs General Neuro 2nd Year

    13/29

    OUTCOMES:

    65% can walk independently @ 6 mos

    Overall, 80% usually recover completely

    5-10% have prolonged course w/ incompleterecovery, ~3% wheelchair bound

    Approx 5% die despite ICU care

    2% will develop chronic relapsing ChronicInflammatory DemyelinatingPolyradiculoneuropathy (CIDP)

  • 7/29/2019 10-11 Gbs General Neuro 2nd Year

    14/29

    REFERENCES:

    Plasmapheresis and acute Guillain-Barre syndrome.The Guillain-Barre Syndrome Study Group.Neurology 1984; 2:1296.

    Ropper, AH. The Guillain-Barre Syndrome. N Engl JMed 1992; 326:1130.

    Sumner, AJ. The physiologic basis for symptoms inGuillain-Barre Syndrome. Ann Neurol 1981; 9Suppl:28.

  • 7/29/2019 10-11 Gbs General Neuro 2nd Year

    15/29

    TICKSPARALYSIS Tick paralysis is the only tick-borne disease that is not

    caused by an infectious organism. The illness is caused bya neurotoxin produced in the tick's salivary gland. Afterprolonged attachment, the engorged tick transmits the toxinto its host. The incidence of tick paralysis is unknown.

    Clinical features:

    Beginning with weakness in both legs that progresses toparalysis. The paralysis ascends to the trunk, arms, andhead within hours and may lead to respiratory failure anddeath. The disease can present as acute ataxia withoutmuscle weakness.

    Patients may report minor sensory symptoms, butconstitutional signs are usually absent. Deep tendonreflexes are usually hypoactive or absent, andophthalmoplegia and bulbar palsy can occur.

  • 7/29/2019 10-11 Gbs General Neuro 2nd Year

    16/29

    TICK

  • 7/29/2019 10-11 Gbs General Neuro 2nd Year

    17/29

    CHRONICINFLAMMATORYDEMYELINATINGPOLYNEUROPATHY (CIDP)

    Both GBS and CIDP are similar most, there areshuttle changes.

    Similarities

    an increased CSF protein a demyelinative type of nerve conduction

    abnormality

    probable autoimmune pathogenesis, and an

    inflammatory pathology.

  • 7/29/2019 10-11 Gbs General Neuro 2nd Year

    18/29

    DIFFERENCES

    A preceding illness is relatively uncommon in patients withCIDP. Whereas GBS is an acute (rarely sub acute)

    monophasic illness

    CIDP evolves more slowly either in a steadily progressiveor stepwise manner (sometimes in an asymmetric pattern)and attains its maximum severity only after weeks, months

    or longer, following which it tends to run a relapsing orfluctuating course.

    Most cases of CIDP respond favourably to the prolongedadministration of corticosteroids, as well as to plasma

    exchange and, in many cases, to intravenous to immuneglobulin

  • 7/29/2019 10-11 Gbs General Neuro 2nd Year

    19/29

    PERONEAL MUSCULAR ATROPHY (CHARCOT-MARIE-TOOTH DISEASE)

    Inherited neuropathy

    Autosomal dominant trait

    Onset

    Late childhood or adolescence, with atrophy of muscles ofthe feet and legs and later of the hands and arms

  • 7/29/2019 10-11 Gbs General Neuro 2nd Year

    20/29

    CLINICALFEATURES

    The early involvement of the peronei and extensors of the

    toes produces an equinovarus deformity and clawfoot. Deep and superficial sensation are impaired, usually to a

    slight degree, and tendon reflexes are absent in theaffected limbs.

    The illness progresses very slowly, with long periods ofstability.

    Wasting seldom extends above the elbows and the lowerthird of the thighs.

    Sensory ataxia and weakness --- instability in gait

  • 7/29/2019 10-11 Gbs General Neuro 2nd Year

    21/29

    DIABETIC NEUROPATHIES

    Diabetic ophthalmoplegia

    Acute mononeuropathy

    Lumbar mononeuropathy multiplex

    proximal diabetic neuropathy distal sensory type

    autonomic involvement

    Segmental radiculopathy

  • 7/29/2019 10-11 Gbs General Neuro 2nd Year

    22/29

    DIABETICOPHTHALMOPLEGIA

    Infarction of the 3rd or 6th cranial nerve

    Occular palsy associated with severe pain aroundthe eye and forehead

    Pupillary constriction ??????

    The pupilloconstrictor fibers, located peripherally inthe third nerve, are spared by the infarction, which

    characteristically affects the central portion of thenerve; hence, pupillary function is usually intact

  • 7/29/2019 10-11 Gbs General Neuro 2nd Year

    23/29

    ACUTEMONONEUROPATHY

    Femoral and sciatic nerve most commonly affected

  • 7/29/2019 10-11 Gbs General Neuro 2nd Year

    24/29

    LUMBARMONONEUROPATHYMULTIPLEX

    Diabetic amyotrophy

    subacutely evolving, painful, asymmetric orunilateral, predominantly motor neuropathy,affecting multiple lumbosacral nerves.

    Muscle weakness and atrophy are most evident inthepelvic girdle and thigh muscles on one side andthe knee jerk is lost.

    Recovery time more months

  • 7/29/2019 10-11 Gbs General Neuro 2nd Year

    25/29

    PROXIMALDIABETICNEUROPATHYI

    symmetric weakness and wasting of the pelvic andproximal thigh muscles, of insidious onset andgradual evolution.

    Scapular and upper arm muscles are affected lessfrequently.

    Pain is not a consistent feature, and sensorychanges, if present, are mild and of the distalsymmetric type.

  • 7/29/2019 10-11 Gbs General Neuro 2nd Year

    26/29

    DISTALSENSORYTYPE

    This takes the form of persistent and oftendistressing pain, numbness, and tingling, affectingthe feet and lower legs symmetrically.

    In severe cases, the hands may be affected.

    Occasionally deep sensation is impaired, withataxia and bladder atony (diabetic pseudotabes)

  • 7/29/2019 10-11 Gbs General Neuro 2nd Year

    27/29

    AUTONOMICINVOLVEMENT

    pupillary and lacrimal

    dysfunction, impairment of sweating and vascular reflexes,nocturnal diarrheoa, atonicity of the gastrointestinal tractand bladder, impotence, and postural hypotension.

    These symptoms are frequently combined with other formsof diabetic neuropathy, particularly with the distal sensorytype

  • 7/29/2019 10-11 Gbs General Neuro 2nd Year

    28/29

    SEGMENTALRADICULOPATHY

    common complication of long-standing diabetes,presenting with severe pain, dysesthesia, andsuperficial sensory loss in a segmental distributionover the chest or abdomen.

    The EMG changes (fibrillations of paraspinalmuscles in multiple myotomes) confirm thepresence of a widespread radiculopathy

  • 7/29/2019 10-11 Gbs General Neuro 2nd Year

    29/29